James W. Huleatt - Concepedia

Author

James W. Huleatt

Yale University

Also Known As

J W Huleatt, James Huleatt, James W Huleatt, James W. Huleatt, James William Huleatt, James W. Huleatt

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Yale University Sanofi (United States)Sanofi (France)VaxInnate (United States)Fundação Oswaldo Cruz

About

James W. Huleatt is an author at Yale University specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	2.8K
2	Allergy	5	5	1.7K
3	Allergy Medicine	2	2	347
4	Engineering	1	1	144
5	Public Health	1	1	19

James W. Huleatt

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen Stephanie C. Eisenbarth, Damani A. Piggott, James W. Huleatt, The Journal of Experimental Medicine AsthmaInflammatory Lung DiseaseLung InflammationAdaptive Immune SystemImmunology	2002	1.2K
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin James W. Huleatt, Valerian Nakaar, Priyanka Desai, Vaccine VaccinationCross-protectionVaccine DevelopmentMedicineTlr5 Ligand Flagellin	2007	385
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity James W. Huleatt, Andrea R. Jacobs, Jie Tang, Vaccine VaccinationToll-like ReceptorsCross-protectionAutoimmune DiseaseRecombinant Fusion Proteins	2006	293
MyD88-dependent induction of allergic Th2 responses to intranasal antigen Damani A. Piggott, Stephanie C. Eisenbarth, Lan Xu, Journal of Clinical Investigation	2005	211
MyD88-dependent induction of allergic Th2 responses to intranasal antigen Damani A. Piggott, Stephanie C. Eisenbarth, Lan Xu, Journal of Clinical Investigation Lung InflammationAllergy MedicineInnate Immune SystemImmunologyImmune Regulation	2005	203
A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity William F. McDonald, James W. Huleatt, Harald G. Foellmer, The Journal of Infectious Diseases ImmunologyImmunodominanceInnate ImmunityImmunotherapyArbovirus	2007	192
Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. James W. Huleatt, Leo Lefrançois The Journal of Immunology Antigen-driven InductionLaboratory ImmunologyAdaptive Immune SystemT-regulatory CellImmune Regulation	1995	166
Engineered Recombinant Peanut Protein and Heat-Killed <i>Listeria monocytogenes</i> Coadministration Protects Against Peanut-Induced Anaphylaxis in a Murine Model Xiu-Min Li, Kamal Srivastava, James W. Huleatt, The Journal of Immunology AsthmaFood AllergyEngineeringAllergy MedicineImmunology	2003	144
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, npj Vaccines	2021	82
Intestinal and Splenic T Cell Responses to Enteric <i>Listeria monocytogenes</i> Infection: Distinct Repertoires of Responding CD8 T Lymphocytes James W. Huleatt, Ingrid M. Pilip, Kristen M. Kerksiek, The Journal of Immunology	2001	66

Page 1